Lonvia Mid-Cap World


Lonvia Mid-Cap World
is a fund invested in small- and mid-cap international equities. Through a highly selective approach to securities, we invest with an asset-based vision, in companies whose business model we consider to be value-creating over the long term. The Product promotes environmental and/or social characteristics in accordance with Article 8 of the SFDR Regulation through normative and sectoral exclusions.

This fund was launched less than a year ago. In accordance with current regulations, its performance cannot yet be published.
Main positions
BAYCURRENT INC3.03 %
XOMETRY INC-A2.86 %
PROCORE TECHNOLOGIES INC2.81 %
ELIXIRR INTERNATIONAL PLC2.71 %
REPLIGEN CORP2.69 %
SARTORIUS STEDIM BIOTECH2.57 %
REPLY SPA2.55 %
FREEE KK2.51 %
SHIFT INC2.48 %
APPIAN CORP-A2.34 %
Total26.55 %
Sector breakdown
Geographical distribution
Key features
Name Lonvia Mid-Cap World
Share type
ISIN code
SRI Label No
SFDR Rules Article 8
Eligibility
Unit launch 18/07/2024
Benchmark index MSCI World Mid Cap Index (NR, USD)
Management company LONVIA Capital
Managing Director Jacques Gout-Lombard
Product type UCITS
Legal status SICAV under Luxembourg law
Custodian CACEIS
Centralizing agent CACEIS
Auditor PWC
Subscription / redemption conditions Daily at 12:00 CET – Unknown NAV – Settlement D+2
Recommended investment period More than 5 years
Minimum investment
Subsequent subscriptions 1 share
Fees
Entry fee (max)
Exit fees (max) 0,00%
Management fees (annual)
Performance fees

Each UCI may not be suitable for all investors. The risks associated with investing in a mutual fund are described in the fund’s Prospectus and Key Information Document (DIC/DICI), which can be downloaded from this website. Please read them carefully.